Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Microarray analysis of mononuclears transcriptome of lung cancer patients

https://doi.org/10.25557/2073-7998.2022.07.33-35

Abstract

Among oncological pathologies lung cancer is the most crucial problem. For revealing of molecular and genetical structure of lung cancer it was conducted transcriptome analysis using material of peripheral blood mononuclears of lung cancer patients and healthy individuals. One-color microarray analysis was used as an essential experimental method. Functional enrichment analysis of gene groups using sources of biological databases (Gene Ontology, KEGG и Reactome) allowed to conduct annotation of obtained results. It was obtained data about differentially expressed gene groups, involved in specific biological signaling pathways. Among them gene clusters of immune response, protein synthesis and cell cycle had maximum level of functional enrichment. Gene cluster of specific and innate immune response components (FCGR2A, FCGR2C, FCGR2B, C5AR, IL6R, CXCL8), and also factors of tuberculosis resistance (ATP6V0B, MAPK14, ITGAX, CORO1A) had decreased level of expression. Decreased expression was also detected for genes, involved in protein synthesis (EIF4A2, EIF4A1, RPL23). For genes of T-cellular signaling pathway (RASGRP1, PDCD1, CD3G, PIK3R1, CD8A) and also for apoptosis factors (PDCD1, CCR7, CCR5, IL1A) was determined enhanced level of their synthesis. Conclusion. Genes that were detected as result of conducted analysis can be used as diagnostic markers of lung cancer development.

About the Authors

V. Yu. Buslaev
Federal Research Centre of Coal and Coal-Chemistry of Siberian Branch of the SD RAS
Russian Federation


V. I. Minina
Federal Research Centre of Coal and Coal-Chemistry of Siberian Branch of the SD RAS; Kemerovo State University
Russian Federation


V. G. Druzhinin
Kemerovo State University
Russian Federation


References

1. Bray F., Ferlay J., Soerjomataram I., et al. Global cancerstatistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018 Nov;68(6):394-424.

2. Malhotra J., Malvezzi M., Negri E., et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016 Sep;48(3):889-902.

3. Wang J., Liu Q., Yuan S., et al. Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep. 2017 Aug;7(1):8371-8384.

4. Han J., Chen M., Wang Y., et al. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Sci Rep. 2018 Jul;8(1):9912-9923.

5. Malone J.H., Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011 May;9(1):34-43.

6. Misono S., Mizuno K., Suetsugu T., et al. Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target. Cancers. 2021 Mar 10;13(6):1187-1203.


Review

For citations:


Buslaev V.Yu., Minina V.I., Druzhinin V.G. Microarray analysis of mononuclears transcriptome of lung cancer patients. Medical Genetics. 2022;21(7):33-35. (In Russ.) https://doi.org/10.25557/2073-7998.2022.07.33-35

Views: 265


ISSN 2073-7998 (Print)